Purinergic receptors regulate myogenic tone in cerebral parenchymal arterioles

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 2, 2013, Pages 293-299

  Brayden, Joseph E ^a   Li, Yao ^a   Tavares, Matthew J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

arterioles; cerebral; myogenic; P2Y receptors; vasoconstriction

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; NUCLEOTIDE; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL CELL; ARTERIOLE; ARTICLE; BLOOD PRESSURE; BRAIN ARTERY; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MUSCLE TONE; MYOGENIC TONE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIOLES; BLOOD PRESSURE; BRAIN; CEREBROVASCULAR CIRCULATION; MALE; MICROCIRCULATION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2;

EID: 84873404753     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.169     Document Type: Article

References (43)

1. Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res 1984; 55: 197-202.
2. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992; 256: 532-535.
3. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 2004; 95: 922-929.
4. Osol G, Laher I, Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 1991; 68: 359-367.
5. Dabertrand F, Nelson MT, Brayden JE. Acidosis dilates brain parenchymal arter-ioles by conversion of calcium waves to sparks to activate BK channels. Circ Res 2012; 110: 285-294.
6. Filosa JA, Bonev AD, Nelson MT. Calcium dynamics in cortical astrocytes and arterioles during neurovascular coupling. Circ Res 2004; 95: e73-e81.
7. Girouard H, Bonev AD, Hannah RM, Meredith A, Aldrich RW, Nelson MT. Astrocytic endfoot Ca2 + and BK channels determine both arteriolar dilation and constriction. Proc Natl Acad Sci USA 2010; 107: 3811-3816.
8. Cipolla MJ, Smith J, Kohlmeyer MM, Godfrey JA. SKCa and IKCa Channels, myo-genic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: effect of ischemia and reperfusion. Stroke 2009; 40: 1451-1457.
9. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K et al. Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 2008; 27: 3092-3103.
10. Nystoriak MA, O'Connor KP, Sonkusare SK, Brayden JE, Nelson MT, Wellman GC. Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarization. Am J Physiol Heart Circ Physiol 2011; 300: H803-H812.
11. Hannah RM, Dunn KM, Bonev AD, Nelson MT. Endothelial SK(Ca) and IK(Ca) channels regulate brain parenchymal arteriolar diameter and cortical cerebral blood flow. J Cereb Blood Flow Metab 2011; 31: 1175-1186.
12. Shirasawa Y, White RP, Robertson JT. Mechanisms of the contractile effect induced by uridine 5-triphosphate in canine cerebral arteries. Stroke 1983; 14: 347-355.
13. Malmsjo M, Hou M, Pendergast W, Erlinge D, Edvinsson L. Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 2003; 3: 4.
14. Malmsjo M, Adner M, Harden TK, Pendergast W, Edvinsson L, Erlinge D. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol 2000; 131: 51-56.
15. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D'Orleans-Juste P et al. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 2010; 85: 204-213.
16. Welsh DG, Brayden JE. Mechanisms of coronary artery depolarization by uridine triphosphate. Am J Physiol Heart Circ Physiol 2001; 280: H2545-H2553.
17. Ko H, Carter RL, Cosyn L, Petrelli R, de Castro S, Besada P et al. Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists. Bioorg Med Chem 2008; 16: 6319-6332.
18. Lazarowski ER, Watt WC, Stutts MJ, Brown HA, Boucher RC, Harden TK. Enzymatic synthesis of UTP gamma S, a potent hydrolysis resistant agonist of P2U-pur-inoceptors. Br J Pharmacol 1996; 117: 203-209.
19. Besada P, Shin DH, Costanzi S, Ko H, Mathe C, Gagneron J et al. Structure-activity relationships of uridine 5-diphosphate analogues at the human P2Y6 receptor. J Med Chem 2006; 49: 5532-5543.
20. Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G. Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br J Pharmacol 1998; 124: 428-430.
21. Robaye B, Boeynaems JM, Communi D. Slow desensitization of the human P2Y6 receptor. Eur J Pharmacol 1997; 329: 231-236.
22. Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan Jr. RM. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol 1999; 276: H33-H41.
23. Marrelli SP, O'Neil RG, Brown RC, Bryan Jr. RM. PLA2 and TRPV4 channels regulate endothelial calcium in cerebral arteries. Am J Physiol Heart Circ Physiol 2007; 292: H1390-H1397.
24. Horiuchi T, Dietrich HH, Tsugane S, Dacey Jr. RG. Analysis of purine-and pyr-imidine-induced vascular responses in the isolated rat cerebral arteriole. Am J Physiol Heart Circ Physiol 2001; 280: H767-H776.
25. Pirotton S, Communi D, Motte S, Janssens R, Boeynaems JM. Endothelial P2-purinoceptors: subtypes and signal transduction. J Auton Pharmacol 1996; 16: 353-356.
26. Marrelli SP. Mechanisms of endothelial P2Y(1)-and P2Y(2)-mediated vasodilatation involve differential [Ca2 +]i responses. Am J Physiol Heart Circ Physiol 2001; 281: H1759-H1766.
27. Malmsjo M, Hou M, Pendergast W, Erlinge D, Edvinsson L. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors. Eur J Pharmacol 2003; 458: 305-311.
28. Inscho EW, LeBlanc EA, Pham BT, White SM, Imig JD. Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 1999; 33: 195-200.
29. Zhao G, Adebiyi A, Blaskova E, Xi Q, Jaggar JH. Type 1 inositol 1, 4, 5-trisphosphate receptors mediate UTP-induced cation currents, Ca2 + signals, and vasoconstriction in cerebral arteries. Am J Physiol Cell Physiol 2008; 295: C1376-C1384.
30. Reading SA, Earley S, Waldron BJ, Welsh DG, Brayden JE. TRPC3 mediates pyr-imidine receptor-induced depolarization of cerebral arteries. Am J Physiol Heart Circ Physiol 2005; 288: H2055-H2061.
31. Takayasu M, Dacey Jr. RG. Calcium dependence of intracerebral arteriolar vaso-motor tone and constrictor responses in rats. Stroke 1989; 20: 778-782.
32. Takayasu M, Bassett JE, Dacey Jr. RG. Effects of calcium antagonists on intracer-ebral penetrating arterioles in rats. J Neurosurg 1988; 69: 104-109.
33. Narayanan J, Imig M, Roman RJ, Harder DR. Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol 1994; 266: H1840-H1845.
34. Westcott EB, Jackson WF. Heterogeneous function of ryanodine receptors, but not IP3 receptors, in hamster cremaster muscle feed arteries and arterioles. Am J Physiol Heart Circ Physiol 2011; 300: H1616-H1630.
35. Gonzales AL, Amberg GC, Earley S. Ca2 + release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol 2010; 299: C279-C288.
36. Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol 2007; 292: H2613-H2622.
37. Crnich R, Amberg GC, Leo MD, Gonzales AL, Tamkun MM, Jaggar JH et al. Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells. Am J Physiol Cell Physiol 2010; 299: C682-C694.
38. Slish DF, Welsh DG, Brayden JE. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol 2002; 283: H2196-H2201.
39. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C et al. International Union of Pharmacology LVIII: update on the P2Y G proteincoupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006; 58: 281-341.
40. Navedo MF, Amberg GC, Nieves M, Molkentin JD, Santana LF. Mechanisms underlying heterogeneous Ca2 + sparklet activity in arterial smooth muscle. J Gen Physiol 2006; 127: 611-622.
41. Storch U, Mederos y Schnitzler M, Gudermann T. G protein-mediated stretch reception. Am J Physiol Heart Circ Physiol 2012; 302: H1241-H1249.
42. Inoue K, Nakazawa K, Ohara-Imaizumi M, Obama T, Fujimori K, Takanaka A. Antagonism by reactive blue 2 but not by brilliant blue G of extracellular ATP-evoked responses in PC12 phaeochromocytoma cells. Br J Pharmacol 1991; 102: 851-854.
43. Mamedova LK, Joshi BV, Gao ZG, von Kugelgen I, Jacobson KA. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem Pharmacol 2004; 67: 1763-1770.